Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$10.3M
-
Value change
-
+$9.3M
-
Number of buys
-
12
-
Number of sells
-
-10
-
Price
-
$0.92
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q3 2022
32 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q3 2022.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 2.05B outstanding shares and own 0.54% of the company stock.
Largest 10 shareholders include Altium Capital Management LP (4.15M shares), SABBY MANAGEMENT, LLC (3.03M shares), ARMISTICE CAPITAL, LLC (2.8M shares), Parkman Healthcare Partners LLC (289K shares), MORGAN STANLEY (263K shares), Atria Wealth Solutions, Inc. (104K shares), RENAISSANCE TECHNOLOGIES LLC (68.2K shares), Apollon Wealth Management, LLC (48.8K shares), PVG ASSET MANAGEMENT CORP (47.9K shares), and LPL Financial LLC (46.6K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.